TABLE 2.
Antimicrobial susceptibility profiles and cnf1 presence of seven E. coli isolates from patients in our seriesa
| Patient | Specimen | ESBL | Amikacin | Ceftriaxone | Ciprofloxacin | Piperacillin-tazobactam | Co-trimoxazole | cnf1 |
|---|---|---|---|---|---|---|---|---|
| 1 | Blood | − | S | S | S | S | S | Not evaluated |
| 2 | Blood | − | S | S | R | S | R | Not evaluated |
| 2 | Fascia | − | S | S | R | S | R | Not evaluated |
| 3 | Blood | + | S | R | R | R | R | Not evaluated |
| 4 | Blood | − | S | S | R | S | R | Negative |
| 5 | Fascia | − | S | S | S | S | S | Positive |
| 6 | Blood | − | S | S | S | S | S | Positive |
| 7 | Blood | − | S | S | R | S | R | Not evaluated |
a
S, sensitive; R, resistant.